SANUWAVE Health, Inc.  

(Public, OTCMKTS:SNWV)   Watch this stock  
Find more results for SNWV)
+0.0050 (6.67%)
May 27 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.08 - 0.08
52 week 0.04 - 0.55
Open 0.08
Vol / Avg. 49,200.00/213,302.00
Mkt cap 4.73M
P/E     -
Div/yield     -
EPS -0.09
Shares 63.06M
Beta 0.54
Inst. own 25%
Aug 4, 2015
Q2 2015 SANUWAVE Health Inc Earnings Release (Estimated) Add to calendar
May 7, 2015
Q1 2015 SANUWAVE Health Inc Earnings Call
May 6, 2015
Q1 2015 SANUWAVE Health Inc Earnings Release
Mar 4, 2015
Q4 2014 SANUWAVE Health Inc Earnings Call
Mar 3, 2015
Q4 2014 SANUWAVE Health Inc Earnings Release

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -550.78% -705.01%
Operating margin -535.47% -703.76%
EBITD margin - -665.88%
Return on average assets -113.99% -191.04%
Return on average equity - -
Employees 8 -
CDP Score - -


11475 Great Oaks Way Ste 150
ALPHARETTA, GA 30022-2482
United States - Map
+1-678-5816843 (Phone)
+1-770-4198634 (Fax)

Website links


SANUWAVE Health, Inc. is a regenerative medicine company focused on the development and commercialization of noninvasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company focuses on developing its Pulsed Acoustic Cellular Expression technology to activate healing in wound conditions, including diabetic foot ulcers, venous ulcers, pressure sores, burns and other skin eruption conditions; orthopedic/spine applications, such as eliminating chronic pain in joints from trauma or arthritis, speeding the healing of fractures, improving bone density in osteoporosis, fusing bones in the extremities and spine, and other potential sports injury applications; plastic/cosmetic applications such as cellulite smoothing, graft and transplant acceptance, skin tightening, scarring and other potential aesthetic uses; and cardiac applications to remove plaque due to atherosclerosis and improving heart muscle performance.

Officers and directors

Kevin A. Richardson II Chairman of the Board, Co-Chief Executive Officer
Age: 46
Barry J. Jenkins Chief Financial Officer, Chief Operating Officer
Age: 52
John F. Nemelka Director
Age: 49
Alan L. Rubino Independent Director
Age: 60